Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Withdrawn study sought to boost RA remission with education and team care
Disease control TerminatedThis study was designed to test whether a combination of an educational booklet, team-based care from a rheumatologist, physical therapist, and psychologist, plus nurse-led phone calls and home symptom tracking, could help more Hispanic adults with rheumatoid arthritis achieve re…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New daily pill could simplify tough bone infection treatment
Disease control OngoingThis study tests a new antibiotic called omadacycline, taken once a day by mouth, against standard antibiotics for bone and joint infections. About 180 adults with these infections will be randomly assigned to receive either omadacycline or the usual care. The goal is to see if o…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Withdrawn study sought to curb obesity in babies of overweight moms
Prevention TerminatedThis study was designed to test whether carefully controlling the amount of breast milk or formula given to babies of overweight mothers could prevent them from becoming obese later in childhood. Researchers planned to enroll mother-infant pairs where the mother had a high BMI. H…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Can a common arthritis drug ease MPS pain? new trial seeks answers.
Symptom relief OngoingThis study tests whether adalimumab, a drug used for arthritis, can reduce pain and improve joint movement in people with MPS I, II, or VI. It includes children and adults aged 5 and older who have significant pain and limited joint motion. Participants receive either adalimumab …
Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Lifestyle overhaul may rewrite Sperm's epigenetic code
Knowledge-focused OngoingThis study looks at how diet and exercise affect the epigenome—chemical marks on DNA—in sperm of overweight Hispanic men. Researchers will compare sperm from 20 healthy active men and 80 obese inactive men before and after a 12-week program of diet, exercise, or both. They will a…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Sleep loss and hormones: a closer look in older men and women
Knowledge-focused OngoingThis study looks at how not getting enough sleep changes stress and sex hormones in healthy adults aged 60 to 80. Researchers will measure cortisol and testosterone levels before and after four nights of limited sleep. The goal is to better understand the body's hormone response …
Phase: EARLY_PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:50 UTC
-
Sleep apnea testosterone study pulled before starting
Knowledge-focused TerminatedThis study was designed to understand how obstructive sleep apnea (OSA) speeds up the natural drop in testosterone as men age. Researchers planned to use CPAP machines—one real, one placebo—to test hormone changes in men aged 30 to 70 with moderate to severe OSA. However, the stu…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:44 UTC